UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Psychometric evaluation of the PROMIS SD-SF-8b instrument in individuals experiencing vasomotor symptoms due to menopause

Health and quality of life outcomes, 2023-11, Vol.21 (1), p.1-126, Article 126

2023

Volltextzugriff (PDF)

Content Validity and Cognitive Debriefing of a Patient-Reported Outcome Instrument Evaluating Symptoms and Disease Impact in Patients with Geographic Atrophy

Ophthalmology and therapy, 2023-04, Vol.12 (2), p.1181-1193

2023

Volltextzugriff (PDF)

Compliance to Advisory Committee on Immunization Practices recommendations for pneumococcal vaccination

Vaccine, 2022-04, Vol.40 (15), p.2274-2281

2022

Volltextzugriff (PDF)

Patient-reported outcomes validated in phase 3 clinical trials: a targeted literature review

Current medical research and opinion, 2023-07, Vol.39 (7), p.955-962

2023

Volltextzugriff (PDF)

P0865A QUALITATIVE STUDY OF PATIENTS' PREFERENCE FOR THE TREATMENT OF ANAEMIA ASSOCIATED WITH CHRONIC KIDNEY DISEASE

Nephrology, dialysis, transplantation, 2020-06, Vol.35 (Supplement_3)

2020

Volltextzugriff (PDF)

Overview of Systematic Reviews (SRs) of Erythropoiesis-Stimulating Agents (ESAs) As Standards of Care for Non-Myeloid Cancer Patients with Chemotherapy-Induced-Anemia (CIA)

Blood, 2021-11, Vol.138 (Supplement 1), p.4152-4152

2021

Volltextzugriff (PDF)

Review and Assessment of Patient-Reported Outcomes (PRO) in Patients with Chemotherapy-Induced Anemia (CIA)

Blood, 2021-11, Vol.138 (Supplement 1), p.5025-5025

2021

Volltextzugriff (PDF)

Psychometric Evaluation of the MENQOL Instrument in Women Experiencing Vasomotor Symptoms Associated with Menopause

Advances in therapy, 2024-06, Vol.41 (6), p.2233-2252

2024

Volltextzugriff (PDF)

Validation and Application of Thresholds to Define Meaningful Change in Vasomotor Symptoms Frequency: Analysis of Pooled SKYLIGHT 1 and 2 Data

Advances in therapy, 2024-07, Vol.41 (7), p.2845-2858

2024

Volltextzugriff (PDF)

Is Intention to Treat Still the Gold Standard or Should Health Technology Assessment Agencies Embrace a Broader Estimands Framework?: Insights and Perspectives From the National Institute for Health and Care Excellence and Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen on the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use E9 (R1) Addendum

Value in health, 2023-02, Vol.26 (2), p.234-242

2023

Volltextzugriff (PDF)

Systematic review and network meta-analysis comparing the efficacy of fezolinetant with hormone and nonhormone therapies for treatment of vasomotor symptoms due to menopause

Menopause (New York, N.Y.), 2024-01, Vol.31 (1), p.68

2024

Volltextzugriff (PDF)

Correction to: Psychometric Evaluation of the MENQOL Instrument in Women Experiencing Vasomotor Symptoms Associated with Menopause

Advances in therapy, 2024-06, Vol.41 (6), p.2543-2543

2024

Volltextzugriff (PDF)

Is Intention to Treat Still the Gold Standard or Should Health Technology Assessment Agencies Embrace a Broader Estimands Framework?

Value in health, 2023-02, Vol.26 (2), p.234-242

2023

Volltextzugriff (PDF)

MO555ASSESSMENT OF HEALTH-RELATED QUALITY OF LIFE (HRQOL) MEASURES FOR PAEDIATRIC PATIENTS WITH ANAEMIA OF CHRONIC KIDNEY DISEASE (CKD)

Nephrology, dialysis, transplantation, 2021-05, Vol.36 (Supplement_1)

2021

Volltextzugriff (PDF)

Preferences for Anaemia Treatment Attributes among Patients with Non-Dialysis-Dependent Chronic Kidney Disease

Advances in therapy, 2023-02, Vol.40 (2), p.641-657

2023

Volltextzugriff (PDF)

Patient Preferences Study for Treatments of Anemia in CKD Patients Not on Dialysis (NDD): PO0289

Journal of the American Society of Nephrology, 2020-10, Vol.31 (10S), p.140-140

2020

Volltextzugriff (PDF)

Fezolinetant impact on health‐related quality of life for vasomotor symptoms due to the menopause: Pooled data from SKYLIGHT 1 and SKYLIGHT 2 randomised controlled trials

BJOG : an international journal of obstetrics and gynaecology, 2024-08, Vol.131 (9), p.1296-1305

2024

Volltextzugriff (PDF)

MO543ASSESSMENT OF RISK FACTORS FOR CARDIOVASCULAR EVENTS AND MORTALITY IN DIALYSIS PATIENTS IN THE AURORA STUDY, A RETROSPECTIVE ANALYSIS

Nephrology, dialysis, transplantation, 2021-05, Vol.36 (Supplement_1)

2021

Volltextzugriff (PDF)

Treatment of moderate-to-severe vasomotor symptoms associated with menopause with fezolinetant: pooled responder analysis from SKYLIGHT 1 and 2

Maturitas, 2023-07, Vol.173, p.75

2023

Volltextzugriff (PDF)

Treating moderate-to-severe menopausal vasomotor symptoms with fezolinetant: analysis of responders using pooled data from two phase 3 studies (SKYLIGHT 1 and 2)

Menopause (New York, N.Y.), 2024-06, Vol.31 (6), p.512

2024

Volltextzugriff (PDF)

Effect of fezolinetant on sleep disturbance and impairment during treatment of vasomotor symptoms due to menopause

Maturitas, 2024-08, Vol.186, p.107999, Article 107999

2024

Volltextzugriff (PDF)

Clinical factors for predicting cardiovascular risk, need for renal replacement therapy, and mortality in patients with non–dialysis-dependent stage 3–5 chronic kidney disease from the Salford Kidney Study

Journal of nephrology, 2023-07, Vol.36 (6), p.1639-1649

2023

Volltextzugriff (PDF)

Management of hip fracture in adults: summary of NICE guidance

BMJ. British medical journal (International ed.), 2011-06, Vol.342 (7812), p.1413

International edition, 2011

Volltextzugriff (PDF)

Management of hip fracture in adults: summary of NICE guidance

BMJ, 2011-06, Vol.342 (jun21 3), p.d3304-d3304

2011

Volltextzugriff (PDF)

Early management of head injury: summary of updated NICE guidance

BMJ (Online), 2014-01, Vol.348 (jan22 2), p.g104-g104

2014

Volltextzugriff (PDF)

1 – 25 von 28

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(27)
Mit Volltextzugriff
(20)

Publikationsform

Artikel
(27)
Dissertationen
(1)

Sprache

Englisch
(28)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Advances In Therapy
(4)
Bmj
(3)
Nephrology, Dialysis, Transplantation
(3)
Blood
(2)
Maturitas
(2)
Menopause
(2)
Value In Health
(2)
Bjog
(1)
Bjog : An International Journal Of Obstetrics And Gynaecology
(1)
Bmj. British Medical Journal
(1)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Psychometric evaluation of the PROMIS SD-SF-8b instrument in individuals experiencing vasomotor symptoms due to menopause

Content Validity and Cognitive Debriefing of a Patient-Reported Outcome Instrument Evaluating Symptoms and Disease Impact in Patients with Geographic Atrophy

Compliance to Advisory Committee on Immunization Practices recommendations for pneumococcal vaccination

Patient-reported outcomes validated in phase 3 clinical trials: a targeted literature review

P0865A QUALITATIVE STUDY OF PATIENTS' PREFERENCE FOR THE TREATMENT OF ANAEMIA ASSOCIATED WITH CHRONIC KIDNEY DISEASE

Overview of Systematic Reviews (SRs) of Erythropoiesis-Stimulating Agents (ESAs) As Standards of Care for Non-Myeloid Cancer Patients with Chemotherapy-Induced-Anemia (CIA)

Review and Assessment of Patient-Reported Outcomes (PRO) in Patients with Chemotherapy-Induced Anemia (CIA)

Psychometric Evaluation of the MENQOL Instrument in Women Experiencing Vasomotor Symptoms Associated with Menopause

Validation and Application of Thresholds to Define Meaningful Change in Vasomotor Symptoms Frequency: Analysis of Pooled SKYLIGHT 1 and 2 Data

Systematic review and network meta-analysis comparing the efficacy of fezolinetant with hormone and nonhormone therapies for treatment of vasomotor symptoms due to menopause

Correction to: Psychometric Evaluation of the MENQOL Instrument in Women Experiencing Vasomotor Symptoms Associated with Menopause

Is Intention to Treat Still the Gold Standard or Should Health Technology Assessment Agencies Embrace a Broader Estimands Framework?

MO555ASSESSMENT OF HEALTH-RELATED QUALITY OF LIFE (HRQOL) MEASURES FOR PAEDIATRIC PATIENTS WITH ANAEMIA OF CHRONIC KIDNEY DISEASE (CKD)

Preferences for Anaemia Treatment Attributes among Patients with Non-Dialysis-Dependent Chronic Kidney Disease

Patient Preferences Study for Treatments of Anemia in CKD Patients Not on Dialysis (NDD): PO0289

Fezolinetant impact on health‐related quality of life for vasomotor symptoms due to the menopause: Pooled data from SKYLIGHT 1 and SKYLIGHT 2 randomised controlled trials

MO543ASSESSMENT OF RISK FACTORS FOR CARDIOVASCULAR EVENTS AND MORTALITY IN DIALYSIS PATIENTS IN THE AURORA STUDY, A RETROSPECTIVE ANALYSIS

Treatment of moderate-to-severe vasomotor symptoms associated with menopause with fezolinetant: pooled responder analysis from SKYLIGHT 1 and 2

Treating moderate-to-severe menopausal vasomotor symptoms with fezolinetant: analysis of responders using pooled data from two phase 3 studies (SKYLIGHT 1 and 2)

Effect of fezolinetant on sleep disturbance and impairment during treatment of vasomotor symptoms due to menopause

Clinical factors for predicting cardiovascular risk, need for renal replacement therapy, and mortality in patients with non–dialysis-dependent stage 3–5 chronic kidney disease from the Salford Kidney Study

Management of hip fracture in adults: summary of NICE guidance

Management of hip fracture in adults: summary of NICE guidance

Early management of head injury: summary of updated NICE guidance

Suchergebnisse filtern